Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Majed M, Hamawy"'
Autor:
John H. Fechner, Hyoung Tae Kim, Tara L. Scheunemann, Huaizhong Hu, Tausif Alam, Jose R. Torrealba, Majed M. Hamawy, Matthew Colburn, Susan Golner, Turan Kanmaz, Zhen Chang, Terry D. Oberley, Stuart J. Knechtle, Drew A. Roenneburg
Publikováno v:
American Journal of Transplantation. 5:58-67
Treating patients with kidney failure by organ transplantation has been extraordinarily successful. Although, current immunosuppressants have improved short-term allograft survival, most transplants are eventually lost due to chronic allograft nephro
Autor:
Terry D. Oberley, Majed M. Hamawy, Jose R. Torrealba, Qingyong Xu, William J. Burlingham, Jacqueline M. Schultz, S Kusaka, Gaby G. M. Doxiadis, Margreet Jonker, Ronald E. Bontrop, Masaaki Katayama, John H. Fechner, Ewa Jankowska-Gan, Jacqueline Wubben, Huaizhong Hu, Stuart J. Knechtle
Publikováno v:
The Journal of Immunology. 172:5753-5764
Approaches that prevent acute rejection of renal transplants in a rhesus monkey model were studied to determine a common mechanism of acceptance. After withdrawal of immunosuppression, all 14 monkeys retained normal allograft function for >6 mo. Of t
Autor:
Yinchen Dong, Jacqueline M. Schultz, Debra D. Bloom, Masaaki Katayama, Terry D. Oberley, Stuart J. Knechtle, Walter Schuler, Turan Kanmaz, Huaizhong Hu, John H. Fechner, Wasim A. Dar, Jose R. Torrealba, Majed M. Hamawy, Judit Markovits, Hyoung Tae Kim
Publikováno v:
Transplantation. 77:914-920
Background.This study assesses the safety and efficacy of the novel human anti-human CD154 monoclonal antibody ABI793 in rhesus monkeys.Methods.Outbred rhesus monkeys were used for renal transplantation from major histocompatibility complex-mismatche
Autor:
Majed M. Hamawy
The high affinity IgE receptor (FceRI) plays a central role in allergic diseases including asthma, allergic rhinitis, atopic dermatitis, food and drug allergy. Manipulating the function of this receptor is important for controlling the onset of aller
Autor:
Majed M. Hamawy, Stuart J. Knechtle
Publikováno v:
Transplantation Reviews. 17:165-171
Cyclosporine and FK506 are immunosuppressive drugs that have been extremely useful for treating graft-versus-host disease and autoimmune and inflammatory diseases, and they have truly revolutionized allograft transplantation. These drugs exert at lea
Autor:
Jon S. Odorico, Hans W. Sollinger, Andreas Friedl, John H. Fechner, Bryan N. Becker, Majed M. Hamawy, John D. Pirsch, Anthony M. D'Alessandro, Yolanda T. Becker, Robert B. Colvin, L. Thomas Chin, Stuart J. Knechtle, Debra D. Bloom, Lauralynn K. Lebeck, Munci Kalayoglu, Huaizhong Hu
Publikováno v:
American Journal of Transplantation. 3:722-730
Campath-1H, an anti-CD52 monoclonal antibody, was used as induction therapy (40 mg i.v. total dose) in 29 primary human renal transplants, and the patients were maintained on rapamycin monotherapy (levels 8-15 ng/mL) post-transplant. Campath-1H profo
Autor:
Majed M. Hamawy
Publikováno v:
Transplantation. 75:1921-1927
In the past two decades, an immense amount of information has been generated on the mechanism of T cell receptor (TCR) signaling (also called signal 1). This overview describes the major signalling pathways in the TCR signal transduction cascade and
Autor:
John H. Fechner, Turan Kanmaz, Huaizhong Hu, Masahiro Tsuchida, Yinchen Dong, Matthew Colburn, Jose R. Torrealba, Hyoung Tae Kim, Terry D. Oberley, Majed M. Hamawy, Stuart J. Knechtle, Jackie Schultz, Luis A. Fernandez, Nobuhiro Ishido, Gokhan Yagci
Publikováno v:
Transplantation. 74:1609-1617
Background. The discovery of new immunosuppressive agents has enhanced short-term graft survival. However, current immunosuppressants often induce toxicities that limit their clinical use. Thus, there is a need for new immunosuppressants for use in c
Publikováno v:
Immunological Reviews. 183:205-213
Studies in non-human primates to evaluate tolerance strategies in organ transplantation have led to innovation in human transplantation. The two strategies we have studied in detail in non-human primates are T-cell depletion by anti-CD3 immunotoxin a
IMMUNOTOXIN FN18-CRM9 INDUCES STRONGER T CELL SIGNALING THAN UNCONJUGATED MONOCLONAL ANTIBODY FN1812
Autor:
Masahiro Tsuchida, Majed M. Hamawy, John H. Fechner, Stuart J. Knechtle, Eric R. Manthei, Clifford S. Cho
Publikováno v:
Transplantation. 72:496-503
Background. The T-cell receptor (TCR)/CD3 complex is the target of therapeutic strategies aimed at prolonging allograft survival. The immunotoxin FN18-CRM9, composed of the anti-CD3 monoclonal antibody FN18 and the mutated diphtheria toxin CRM9, is u